Decrypting the multifaceted peripheral neuropathy based on molecular pathology and therapeutics: a comprehensive review

Bibliography

• Aiyer, R., Barkin, R.L., and Bhatia, A., 2017. Treatment of neuropathic pain with venlafaxine: a systematic review. Pain medicine (Malden, Mass.), 18 (10), 1999–2012. doi: 10.1093/pm/pnw261.
   PubMed Web of Science ®Google Scholar
• Andersen Hammond, E., Pitz, M., and Shay, B., 2019. Neuropathic pain in taxane-induced peripheral neuropathy: evidence for exercise in treatment. Neurorehabilitation and neural repair, 33 (10), 792–799. doi: 10.1177/1545968319860486.
   PubMed Web of Science ®Google Scholar
• Areti, A., et al., 2014. Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy. Redox biology, 2, 289–295. doi: 10.1016/j.redox.2014.01.006.
   PubMed Web of Science ®Google Scholar
• Atalay, S., Jarocka-Karpowicz, I., and Skrzydlewska, E., 2019. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants, 9 (1), 21. doi: 10.3390/antiox9010021.
   Web of Science ®Google Scholar
• Bai, Y.-W., et al., 2023. Repetitive transcranial magnetic stimulation regulates neuroinflammation in neuropathic pain. Frontiers in immunology, 14, 1172293. doi: 10.3389/fimmu.2023.1172293.
   PubMed Web of Science ®Google Scholar
• Bureau, B.L., et al., 2020. Peripheral neuropathy as a complication of SARS-Cov-2. Cureus, 12 (11), e11452. doi: 10.7759/cureus.11452.
   PubMed Web of Science ®Google Scholar
• Casale, R., et al., 2021. Food for special medical purposes and nutraceuticals for pain: a narrative review. Pain and therapy, 10 (1), 225–242. doi: 10.1007/s40122-021-00239-y.
   PubMed Web of Science ®Google Scholar
• Charalambous, M., et al., 2020. Repetitive transcranial magnetic stimulation in drug-resistant idiopathic epilepsy of dogs: a noninvasive neurostimulation technique. Journal of veterinary internal medicine, 34 (6), 2555–2561. doi: 10.1111/jvim.15919.
   PubMed Web of Science ®Google Scholar
• Chopra, K., and Tiwari, V., 2012. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. British journal of clinical pharmacology, 73 (3), 348–362. doi: 10.1111/j.1365-2125.2011.04111.x.
   PubMed Web of Science ®Google Scholar
• Cojocaru, I.M., et al., 2014. Peripheral nervous system manifestations in systemic autoimmune diseases. Maedica a journal of clinical medicine, 9 (3), 289.
   Google Scholar
• De Andrade, E.M., et al., 2020. Neurochemical effects of motor cortex stimulation in the periaqueductal gray during neuropathic pain. Journal of neurosurgery, 132 (1), 239–251. doi: 10.3171/2018.7.JNS173239.
   Web of Science ®Google Scholar
• D’Egidio, F., et al., 2022. The influence of dietary supplementations on neuropathic pain. Life, 12 (8), 1125. doi: 10.3390/life12081125.
   PubMedGoogle Scholar
• Di Cesare Mannelli, L., et al., 2012. Oxaliplatin-induced neuropathy: oxidative stress as pathological mechanism. Protective effect of silibinin. The journal of pain, 13 (3), 276–284. doi: 10.1016/j.jpain.2011.11.009.
   PubMed Web of Science ®Google Scholar
• Di Stefano, G., et al., 2019. Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review. Journal of pain research, 12, 1341–1351. doi: 10.2147/JPR.S190231.
   PubMed Web of Science ®Google Scholar
• Dudek, I., et al., 2020. Alcohol-induced neuropathy in chronic alcoholism: causes, pathophysiology, diagnosis, and treatment options. Current pathobiology reports, 8 (4), 87–97. doi: 10.1007/s40139-020-00214-w.
   Google Scholar
• Eid, S., et al., 2019. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia, 62 (9), 1539–1549. doi: 10.1007/s00125-019-4959-1.
   PubMed Web of Science ®Google Scholar
• Ercolini, A.M., and Miller, S.D., 2009. The role of infections in autoimmune disease. Clinical and experimental immunology, 155 (1), 1–15. doi: 10.1111/j.1365-2249.2008.03834.x.
   PubMed Web of Science ®Google Scholar
• Fattori, V., et al., 2016. Capsaicin: current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses. Molecules (Basel, Switzerland), 21 (7), 844. doi: 10.3390/molecules21070844.
   PubMed Web of Science ®Google Scholar
• Fortino, V.R., Pelaez, D., and Cheung, H.S., 2013. Concise review: stem cell therapies for neuropathic pain. Stem cells translational medicine, 2 (5), 394–399. doi: 10.5966/sctm.2012-0122.
   PubMed Web of Science ®Google Scholar
• Freeman, M.R., 2014. Signaling mechanisms regulating Wallerian degeneration. Current opinion in neurobiology, 27, 224–231. doi: 10.1016/j.conb.2014.05.001.
   PubMed Web of Science ®Google Scholar
• Gandhi, M., et al., 2022. Diabetes: how to manage diabetic peripheral neuropathy. Drugs in context, 11, 1–13. doi: 10.7573/dic.2021-10-2.
   Google Scholar
• Greig, M., et al., 2014. Insights into the pathogenesis and treatment of painful diabetic neuropathy. In: Handbook of Clinical Neurology. The Netherlands: Elsevier B.V., 559–578. doi: 10.1016/B978-0-444-53480-4.00037-0.
   Google Scholar
• Gutiérrez, J., et al., 2021. Advances in imaging technologies for the assessment of peripheral neuropathies in rheumatoid arthritis. Rheumatology international, 41 (3), 519–528. doi: 10.1007/s00296-020-04780-5.
   PubMed Web of Science ®Google Scholar
• Hammoud, N., and Jimenez-Shahed, J., 2019. Chronic neurologic effects of alcohol. Clinics in liver disease, 23 (1), 141–155. doi: 10.1016/j.cld.2018.09.010.
   PubMed Web of Science ®Google Scholar
• Haroutounian, S., et al., 2014. Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy. Pain, 155 (7), 1272–1279. doi: 10.1016/j.pain.2014.03.022.
   PubMed Web of Science ®Google Scholar
• Jiang, L., Jones, S., and Jia, X., 2017. Stem cell transplantation for peripheral nerve regeneration: current options and opportunities. International journal of molecular sciences, 18 (1), 94. doi: 10.3390/ijms18010094.
   PubMed Web of Science ®Google Scholar
• Jin, L., and Liu, Y., 2021. Clinical manifestations, pathogenesis, diagnosis and treatment of peripheral neuropathies in connective tissue diseases: more diverse and frequent in different subtypes than expected. Diagnostics, 11 (11), 1956. doi: 10.3390/diagnostics11111956.
   Web of Science ®Google Scholar
• Kabir, M.T., et al., 2021. Therapeutic potential of polyphenols in the management of diabetic neuropathy. Evidence-based complementary and alternative medicine, 2021, 1–20. doi: 10.1155/2021/9940169.
   Web of Science ®Google Scholar
• Kaeley, N., et al., 2019. Prevalence and patterns of peripheral neuropathy in patients of rheumatoid arthritis. Journal of family medicine and primary care, 8 (1), 22–26. doi: 10.4103/jfmpc.jfmpc_260_18.
   PubMedGoogle Scholar
• Kessler, J.A., et al., 2021. Gene therapy for diabetic peripheral neuropathy: a randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clinical and translational science, 14 (3), 1176–1184. doi: 10.1111/cts.12977.
   PubMed Web of Science ®Google Scholar
• Kocot-Kępska, M., et al., 2021. Peripheral mechanisms of neuropathic pain—the role of neuronal and non-neuronal interactions and their implications for topical treatment of neuropathic pain. Pharmaceuticals, 14 (2), 77. doi: 10.3390/ph14020077.
   Web of Science ®Google Scholar
• Kumar, B., Das, M., and Misra, A., 2020. A cross-sectional study of association of serostatus and extra-articular manifestations in patients with rheumatoid arthritis in a teaching hospital. Journal of family medicine and primary care, 9 (6), 2789–2793. doi: 10.4103/jfmpc.jfmpc_99_20.
   PubMedGoogle Scholar
• Kuwabara, S., 2004. Guillain-Barré Syndrome Epidemiology, Pathophysiology and Management. Drugs, 64 (6), 597–610. doi: 10.2165/00003495-200464060-00003.
   PubMed Web of Science ®Google Scholar
• Lehmann, H.C., et al., 2020. Diagnosis of peripheral neuropathy. Neurological research and practice, 2 (1), 20. doi: 10.1186/s42466-020-00064-2.
   PubMedGoogle Scholar
• Liampas, A., et al., 2020. Non-pharmacological management of painful peripheral neuropathies: a systematic review. Advances in therapy, 37 (10), 4096–4106. doi: 10.1007/s12325-020-01462-3.
   PubMed Web of Science ®Google Scholar
• Lopez, G., et al., 2022. A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy. Scientific reports, 12 (1), 19023. doi: 10.1038/s41598-022-23372-w.
   PubMed Web of Science ®Google Scholar
• Maatoug, R., et al., 2021. Non-invasive and invasive brain stimulation in alcohol use disorders: a critical review of selected human evidence and methodological considerations to guide future research. Comprehensive psychiatry, 109, 152257. doi: 10.1016/j.comppsych.2021.152257.
   PubMed Web of Science ®Google Scholar
• Martyn, C.N., and Hughes, R.A., 1997. Epidemiology of peripheral neuropathy. Journal of neurology, neurosurgery, and psychiatry, 62 (4), 310–318. doi: 10.1136/jnnp.62.4.310.
   PubMed Web of Science ®Google Scholar
• Mathot, F., Shin, A.Y., and Van Wijnen, A.J., 2019. Targeted stimulation of MSCs in peripheral nerve repair. Gene, 710, 17–23. doi: 10.1016/j.gene.2019.02.078.
   PubMed Web of Science ®Google Scholar
• Mika, J., et al., 2013. Importance of glial activation in neuropathic pain. European journal of pharmacology, 716 (1-3), 106–119. doi: 10.1016/j.ejphar.2013.01.072.
   PubMed Web of Science ®Google Scholar
• Mishra, G., et al., 2022. Nutraceuticals: a source of benefaction for neuropathic pain and fibromyalgia. Journal of functional foods, 97, 105260. doi: 10.1016/j.jff.2022.105260.
   Web of Science ®Google Scholar
• Monfrini, M., et al., 2017. Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy. Experimental neurology, 288, 75–84. doi: 10.1016/j.expneurol.2016.11.006.
   PubMed Web of Science ®Google Scholar
• Mounier, N.M., et al., 2020. Chemotherapy-induced cognitive impairment (CICI): an overview of etiology and pathogenesis. Life sciences, 258, 118071. doi: 10.1016/j.lfs.2020.118071.
   PubMed Web of Science ®Google Scholar
• Murillo, L.C., Sutachan, J.J., and Albarracín, S.L., 2023. An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI). Toxicology reports, 10, 544–553. doi: 10.1016/j.toxrep.2023.04.015.
   PubMedGoogle Scholar
• Musiał-Wysocka, A., Kot, M., and Majka, M., 2019. The pros and cons of mesenchymal stem cell-based therapies. Cell transplantation, 28 (7), 801–812. doi: 10.1177/0963689719837897.
   PubMed Web of Science ®Google Scholar
• Nazir, M., Lone, R., and Charoo, B.A., 2019. Infantile thiamine deficiency: new insights into an old disease. Indian pediatrics, 56 (8), 673–681.
   PubMed Web of Science ®Google Scholar
• Oaklander, A.L., et al., 2022. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurology(R) neuroimmunology & neuroinflammation, 9 (3), e1146.
   PubMed Web of Science ®Google Scholar
• Obata, H., 2017. Analgesic mechanisms of antidepressants for neuropathic pain. International journal of molecular sciences, 18 (11), 2483. doi: 10.3390/ijms18112483.
   PubMed Web of Science ®Google Scholar
• Patel, M., et al., 2023. Molecular pathology and therapeutics of the diabetic foot ulcer; comprehensive reviews. Archives of physiology and biochemistry, 1–8. doi: 10.1080/13813455.2023.2219863.
   Web of Science ®Google Scholar
• Papadopoulou, M., et al., 2023. Non-pharmacological interventions on pain and quality of life in chemotherapy induced polyneuropathy: systematic review and meta-analysis. In vivo (Athens, Greece), 37 (1), 47–56. doi: 10.21873/invivo.13053.
   PubMed Web of Science ®Google Scholar
• Phatale, S., and shete, A., 2014. Chronic Alcoholism and its Effect on Nerve Conduction Velocity. International journal of recent trends in science and technology, 4 (1), 4–6.
   Google Scholar
• Purohit, V., et al., 2008. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol (Fayetteville, N.Y.), 42 (5), 349–361. doi: 10.1016/j.alcohol.2008.03.131.
   PubMed Web of Science ®Google Scholar
• Püsküllüoğlu, M., et al., 2022. Effects of transcutaneous electrical nerve stimulation on pain and chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review. Medicina (Medicina), 58 (2), 284. doi: 10.3390/medicina58020284.
   PubMedGoogle Scholar
• Quartu, M., et al., 2014. Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the Rat DRG, spinal cord, and sciatic nerve. Biomed research international, 2014, 180428–19. doi: 10.1155/2014/180428.
   PubMed Web of Science ®Google Scholar
• Sekiguchi, K., et al., 2019. Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: a randomized double-blind placebo-controlled study in Japan. Journal of diabetes investigation, 10 (2), 466–474. doi: 10.1111/jdi.12890.
   PubMed Web of Science ®Google Scholar
• Seretny, M., et al., 2014. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain, 155 (12), 2461–2470. doi: 10.1016/j.pain.2014.09.020.
   PubMed Web of Science ®Google Scholar
• Snyder, M.J., Gibbs, L.M., and Lindsay, T.J., 2016. Treating painful diabetic peripheral neuropathy: an update. American Family Physician, 94 (3), 227–234.
   Google Scholar
• Starobova, H., and Vetter, I., 2017. Pathophysiology of chemotherapy-induced peripheral neuropathy. Frontiers in molecular neuroscience, 10, 174. doi: 10.3389/fnmol.2017.00174.
   PubMed Web of Science ®Google Scholar
• Teng, C., et al., 2023. Evaluating laser photobiomodulation for chemotherapy-induced peripheral neuropathy: a randomised phase II trial. Supportive care in cancer, 31 (1), 52. doi: 10.1007/s00520-022-07463-y.
   PubMed Web of Science ®Google Scholar
• Tesfaye, S., et al., 2010. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes care, 33 (10), 2285–2293. doi: 10.2337/dc10-1303.
   PubMed Web of Science ®Google Scholar
• Tesfaye, S., and Selvarajah, D., 2012. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes/metabolism research and reviews, 28 (Suppl. 1), 8–14. doi: 10.1002/dmrr.2239.
   PubMed Web of Science ®Google Scholar
• Thenmozhi, R., et al., 2020. Gene therapy options as new treatment for inherited peripheral neuropathy. Experimental neurobiology, 29 (3), 177–188. doi: 10.5607/en20004.
   PubMed Web of Science ®Google Scholar
• Titolo, P., et al., 2020. Transfer of the peroneal component of the sciatic nerve in total brachial plexus lesion: an anatomical feasibility study. Injury, 51 (12), 2904–2909. doi: 10.1016/j.injury.2020.03.015.
   PubMed Web of Science ®Google Scholar
• Trivedi, S., et al., 2017. Epidemiology of peripheral neuropathy: an Indian perspective. Annals of Indian academy of neurology, 20 (3), 173–184. doi: 10.4103/aian.AIAN_470_16.
   PubMed Web of Science ®Google Scholar
• Van Den Berg, B., et al., 2014. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature reviews. Neurology, 10 (8), 469–482. doi: 10.1038/nrneurol.2014.121.
   PubMed Web of Science ®Google Scholar
• Xu, D.H., et al., 2020. The effectiveness of topical cannabidiol oil in symptomatic relief of peripheral neuropathy of the lower extremities. Current pharmaceutical biotechnology, 21 (5), 390–402. doi: 10.2174/1389201020666191202111534.
   PubMed Web of Science ®Google Scholar
• Yang, H., et al., 2019. New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection, and precision medicine. Frontiers in endocrinology, 10, 929. doi: 10.3389/fendo.2019.00929.
   PubMed Web of Science ®Google Scholar
• Yang, K., et al., 2022. Progress in the treatment of diabetic peripheral neuropathy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 148, 112717. doi: 10.1016/j.biopha.2022.112717.
   PubMed Web of Science ®Google Scholar
• Yang, S., and Chang, M.C., 2021. Transcranial direct current stimulation for the management of neuropathic pain: a narrative review. Pain Physician, 24 (6), E771–E781.
   PubMed Web of Science ®Google Scholar
• Zajaczkowską, R., et al., 2019. Mechanisms of chemotherapy-induced peripheral neuropathy. International journal of molecular sciences, 20 (6), 1451.
   PubMed Web of Science ®Google Scholar
• Zakin, E., Abrams, R., and Simpson, D.M., 2019. Diabetic neuropathy. Seminars in neurology, 39 (5), 560–569. doi: 10.1055/s-0039-1688978.
   PubMed Web of Science ®Google Scholar
• Zeng, H., et al., 2020. Non-invasive neuromodulation effects on painful diabetic peripheral neuropathy: a systematic review and meta-analysis. Scientific reports, 10 (1), 19184. doi: 10.1038/s41598-020-75922-9.
   PubMed Web of Science ®Google Scholar